ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,348.82
-0.08%
Dow Jones
38,845.62
-0.10%
US Dollar vs MXN
18.4271
3.02%
Brent Oil
79.265
-0.77%
Bitcoin
68,939.98
-2.58%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) Noticias

AZTR Azitra Inc

0.15
-0.0151 (-9.15%)
Última actualización: 14:11:08
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Azitra Inc AZTR AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0151 -9.15% 0.15 14:11:08
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.165 0.15 0.1708 0.1651
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
03/6/202415:30EDGAR2Form DEF 14A - Other definitive proxy statements
31/5/202407:00BWAzitra, Inc. Announces Presentation at the 2024 BIO..
24/5/202415:55EDGAR2Form PRE 14A - Other preliminary proxy statements
17/5/202407:00BWAzitra, Inc. Announces Positive Preclinical Data from ATR-04..
10/5/202407:00BWAzitra, Inc. Announces Positive Preclinical Data of ATR-12..
09/5/202416:05EDGAR2Form 8-K - Current report
09/5/202416:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202416:00BWAzitra, Inc. Announces Q1 2024 Financial Results and..
22/4/202415:30BWAzitra, Inc. Announces New Preclinical Data to be Presented..
18/4/202415:15BWAzitra, Inc. to Present New Data at Three Upcoming..
15/3/202415:15BWAzitra, Inc. Announces Full Year 2023 Financial Results and..
26/2/202415:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/2/202415:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/2/202415:05BWAzitra, Inc. Announces Closing of Public Offering
15/2/202419:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202419:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202415:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202408:15EDGAR2Form 8-K - Current report
13/2/202421:09BWAzitra, Inc. Announces Pricing of Public Offering
19/1/202410:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
19/1/202408:19EDGAR2Form S-1 - General form for registration of securities under..
16/1/202408:00BWAzitra, Inc. Strengthens Intellectual Property Portfolio..
03/1/202408:00BWAzitra, Inc. to Present at Biotech Showcase 2024 and the..
04/12/202315:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202315:30BWAzitra, Inc. Announces Third Quarter 2023 Financial Results..
16/10/202307:00BWAzitra to Present at the ThinkEquity Conference
03/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202307:00PRNUSAzitra to Present at the H.C. Wainwright 25th Annual Global..
14/8/202315:11EDGAR2Form 8-K - Current report
14/8/202315:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202315:05PRNUSAzitra, Inc. Announces Second Quarter 2023 Financial Results..
19/7/202315:05PRNUSAzitra Adds Biotech Leaders Barbara Ryan and John Schroer to..
11/7/202315:05EDGAR2Form 8-K - Current report
11/7/202315:05PRNUSAzitra, Inc. Appoints Travis Whitfill as Chief Operating..
07/7/202315:05EDGAR2Form 8-K - Current report
03/7/202314:04EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/6/202315:56EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
21/6/202317:46PRNUSAzitra, Inc. Announces Closing of Initial Public Offering
15/6/202318:04PRNUSAzitra, Inc. Announces Pricing of Initial Public Offering

Su Consulta Reciente

AMEX
AZTR
Azitra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados